Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 221.4 SEK 4.04% Market Closed
Market Cap: 30B SEK
Have any thoughts about
Vitrolife AB?
Write Note

Vitrolife AB
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vitrolife AB
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Vitrolife AB
STO:VITR
Gross Profit
kr2.1B
CAGR 3-Years
27%
CAGR 5-Years
18%
CAGR 10-Years
20%
Biogaia AB
STO:BIOG B
Gross Profit
kr950.2m
CAGR 3-Years
20%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Gross Profit
kr752.8m
CAGR 3-Years
60%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Probi AB
STO:PROB
Gross Profit
kr211.3m
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
15%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Gross Profit
kr20B
CAGR 3-Years
19%
CAGR 5-Years
17%
CAGR 10-Years
30%
BioArctic AB
STO:BIOA B
Gross Profit
kr565.1m
CAGR 3-Years
144%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
No Stocks Found

Vitrolife AB
Glance View

Market Cap
30B SEK
Industry
Biotechnology

Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 427 full-time employees. The company went IPO on 2001-06-26. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. The company also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The firm is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

VITR Intrinsic Value
139.61 SEK
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Vitrolife AB's Gross Profit?
Gross Profit
2.1B SEK

Based on the financial report for Sep 30, 2024, Vitrolife AB's Gross Profit amounts to 2.1B SEK.

What is Vitrolife AB's Gross Profit growth rate?
Gross Profit CAGR 10Y
20%

Over the last year, the Gross Profit growth was 7%. The average annual Gross Profit growth rates for Vitrolife AB have been 27% over the past three years , 18% over the past five years , and 20% over the past ten years .

Back to Top